Lactobacillus plantarum inhibits epithelial barrier dysfunction and interleukin-8 secretion induced by tumor necrosis factor-alpha

World J Gastroenterol. 2007 Apr 7;13(13):1962-5. doi: 10.3748/wjg.v13.i13.1962.

Abstract

Aim: To determine whether Lactobacillus plantarum can modify the deleterious effects of tumor necrosis factor-alpha (TNF-alpha) on intestinal epithelial cells.

Methods: Caco-2 cells were incubated with TNF-alpha alone or in the presence of L. plantarum. Transepithelial electrical resistance was used to measure epithelial barrier function. Interleukin 8 (IL-8) secretion by intestinal epithelial cells was measured using an ELISA. Cellular lysate proteins were immunoblotted using the anti-extracellular regulated kinase (ERK), anti-phospho-ERK and anti-IkappaB-alpha.

Results: A TNF-alpha-induced decrease in transepithelial electrical resistance was inhibited by L. plantarum. TNF-alpha-induced IL-8 secretion was reduced by L. plantarum. L. plantarum inhibited the activation of ERK and the degradation of IkappaB-alpha in TNF-alpha-treated Caco-2 cells.

Conclusion: Induction of epithelial barrier dysfunction and IL-8 secretion by TNF-alpha is inhibited by L. plantarum. Probiotics may preserve epithelial barrier function and inhibit the inflammatory response by altering the signal transduction pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenocarcinoma / metabolism
  • Adenocarcinoma / pathology
  • Adenocarcinoma / physiopathology
  • Caco-2 Cells
  • Colonic Neoplasms / metabolism
  • Colonic Neoplasms / pathology
  • Colonic Neoplasms / physiopathology
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • I-kappa B Proteins / metabolism
  • Interleukin-8 / metabolism*
  • Intestinal Absorption / drug effects
  • Intestinal Absorption / physiology*
  • Intestinal Mucosa / drug effects
  • Intestinal Mucosa / physiology*
  • Lactobacillus plantarum*
  • Membrane Potentials / drug effects
  • Membrane Potentials / physiology
  • NF-KappaB Inhibitor alpha
  • Probiotics / pharmacology*
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • I-kappa B Proteins
  • Interleukin-8
  • NFKBIA protein, human
  • Tumor Necrosis Factor-alpha
  • NF-KappaB Inhibitor alpha
  • Extracellular Signal-Regulated MAP Kinases